Klein, Bernard

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

Moreaux, J., Legouffe, E., Jourdan, E., Quittet, P., Rème, T., Lugagne, C., Moine, P., Rossi, J.-F., Klein, B., & Tarte, K. (2004) · Blood

Multiple Myeloma Research and TreatmentsCell death mechanisms and regulation

Cited by 558

Bone marrow mesenchymal stem cells are abnormal in multiple myeloma

Corre, J., Mahtouk, K., Attal, M., Gadelorge, M., Huynh, A., Fleury-Cappellesso, S., Danho, C., Laharrague, P., Klein, B., Rème, T., et al. (2007) · Leukemia

Multiple Myeloma Research and TreatmentsHematopoietic Stem Cell Transplantation

Cited by 328

Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma

Mahtouk, K., Cremer, F. W., Rème, T., Jourdan, M., Baudard, M., Moreaux, J., Requirand, G., Fiol, G., De Vos, J., Moos, M., et al. (2006) · Oncogene

Multiple Myeloma Research and TreatmentsProteoglycans and glycosaminoglycans research

Cited by 105

The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells

Tarte, K., Jourdan, M., Veyrune, J. L., Berberich, I., Fiol, G., Redal, N., Shaughnessy, J., & Klein, B. (2004) · British Journal of Haematology

Multiple Myeloma Research and TreatmentsCell death mechanisms and regulation

Cited by 28

The Glycome of Normal and Malignant Plasma Cells

Moehler, T. M., Seckinger, A., Hose, D., Andrulis, M., Moreaux, J., Hielscher, T., Willhauck-Fleckenstein, M., Merling, A., Bertsch, U., Jauch, A., et al. (2013) · PLoS ONE

Multiple Myeloma Research and TreatmentsGlycosylation and Glycoproteins Research

Cited by 17